MX2023006909A - Use of phenoxypropylamine compounds to treat depression. - Google Patents
Use of phenoxypropylamine compounds to treat depression.Info
- Publication number
- MX2023006909A MX2023006909A MX2023006909A MX2023006909A MX2023006909A MX 2023006909 A MX2023006909 A MX 2023006909A MX 2023006909 A MX2023006909 A MX 2023006909A MX 2023006909 A MX2023006909 A MX 2023006909A MX 2023006909 A MX2023006909 A MX 2023006909A
- Authority
- MX
- Mexico
- Prior art keywords
- compositions
- formula
- disclosed
- methods
- compound
- Prior art date
Links
- DXVQSHRBALIFBC-UHFFFAOYSA-N 3-phenoxypropan-1-amine Chemical class NCCCOC1=CC=CC=C1 DXVQSHRBALIFBC-UHFFFAOYSA-N 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 abstract 7
- 150000001875 compounds Chemical class 0.000 abstract 2
- 102100022738 5-hydroxytryptamine receptor 1A Human genes 0.000 abstract 1
- 101710138638 5-hydroxytryptamine receptor 1A Proteins 0.000 abstract 1
- 230000003042 antagnostic effect Effects 0.000 abstract 1
- 230000003467 diminishing effect Effects 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
- 208000024891 symptom Diseases 0.000 abstract 1
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 abstract 1
Landscapes
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Disclosed herein are compositions and methods for treating depression using compositions comprising a compound of formula I. Disclosed herein are compositions and methods for treating depression using compositions comprising phenoxypropylamine compounds and derivatives having selective affinity for and antagonistic activity against the 5-HT1A receptor, as well as 5-HT reuptake inhibitory activity. In addition, compositions and methods for treating depression using compositions comprising a compound of formula II are disclosed. Methods of treating or diminishing at least one symptom of depression in a human subject with a composition comprising a compound of the formula (I) or formula (II), or a pharmaceutically acceptable salt, hydrate, or solvate thereof, are also disclosed.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361756208P | 2013-01-24 | 2013-01-24 | |
| US201361799482P | 2013-03-15 | 2013-03-15 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2023006909A true MX2023006909A (en) | 2023-06-26 |
Family
ID=87758745
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2021014783A MX2021014783A (en) | 2013-01-24 | 2014-01-24 | Use of phenoxypropylamine compounds to treat depression. |
| MX2023006909A MX2023006909A (en) | 2013-01-24 | 2015-07-22 | Use of phenoxypropylamine compounds to treat depression. |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2021014783A MX2021014783A (en) | 2013-01-24 | 2014-01-24 | Use of phenoxypropylamine compounds to treat depression. |
Country Status (1)
| Country | Link |
|---|---|
| MX (2) | MX2021014783A (en) |
-
2014
- 2014-01-24 MX MX2021014783A patent/MX2021014783A/en unknown
-
2015
- 2015-07-22 MX MX2023006909A patent/MX2023006909A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MX2021014783A (en) | 2023-07-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12018502125A1 (en) | Bipyrazole derivatives as jak inhibitors | |
| AU2018236800B2 (en) | DNA-PK inhibitors | |
| PH12016500105A1 (en) | Sulfonamides as modulators of sodium channels | |
| MD4800B1 (en) | Aminopyrimidinyl compounds as JAK inhibitors | |
| PH12016500170A1 (en) | Formulation of syk inhibitors | |
| NZ711424A (en) | Pyridine derivatives as soft rock inhibitors | |
| MY186547A (en) | 4?-fluoro-2?-methyl substituted nucleoside derivatives | |
| PH12015502118A1 (en) | Pyridin-4-yl derivatives | |
| UA117032C2 (en) | A selective inhibitor of phosphatidylinositol 3-kinase-gamma | |
| EA032271B9 (en) | Compounds, pharmaceutical composition and methods for use in treating inflammatory diseases | |
| PH12015501643B1 (en) | Methods of use of phenoxypropylamine compounds to treat depression | |
| PH12017501736A1 (en) | Indole derivatives | |
| MX2023006909A (en) | Use of phenoxypropylamine compounds to treat depression. | |
| PH12015502703A1 (en) | Pharmaceutical compositions | |
| EA201500446A1 (en) | PHARMACEUTICAL COMPOSITION TO REDUCE N-OXIDE TRIMETYLAMINE LEVEL | |
| WO2014147636A8 (en) | 5-amino-quinoline-8-carboxamide derivatives as 5-ht4 receptor agonists | |
| MX2017013103A (en) | Methods for the treatment of cardiovascular disorders. |